Isoflavone is a type of phytoestrogen that exists in soy-based products. Previous studies have reported that certain foods containing isoflavones, particularly infant formula, may have potential adverse effects on male reproductive function. However, few studies have focused on the effects of isoflavones on testosterone biosynthesis and Sertoli cell function during the neonatal period. The aim of the present study was to investigate the influence of daidzein, a common isoflavone, on testosterone secretion and Sertoli cell function during the neonatal period. The organ culture method was used to assess the effects of daidzein on neonatal mouse testes. Cultured testes were treated with daidzein (0, 0.03, 0.3, 3 or 30 µmol/l) for 72 h. To verify the mechanism of action of daidzein on androgen production, Leydig cells were also treated with daidzein for 24 h. As anticipated, testosterone secretions were suppressed by daidzein (30 µmol/l) in cultured testes and Leydig cells. Further analysis demonstrated that the expression levels of steroidogenic acute regulatory protein (StAR), cholesterol side-chain cleavage enzyme (P450scc) and 3β-hydroxysteroid dehydrogenase (3β-HSD), which are transport proteins and key enzymes in androgen biosynthesis, were suppressed in cultured neonatal mouse testes. In addition, the expression levels of StAR, P450scc, 3β-HSD and 17α-hydroxylase/20-lyase were decreased in Leydig cells. Notably, proliferation of Sertoli cells was also inhibited by daidzein (30 µmol/l). Furthermore, the expression levels of vimentin were significantly suppressed in the testes following treatment with daidzein, whereas inhibin B expression exhibited no change. In conclusion, daidzein may suppress steroidogenic capability and impair Sertoli cell function in the neonatal period in vitro.
Introduction
There is growing public concern regarding the adverse effects of environmental chemicals with an estrogenic influence on reproductive health. Phytoestrogens, including daidzein, genistein and coumestrol, are defined as estrogenic compounds. Daidzein and genistein, among all types of isoflavones, are widely distributed in the daily human diet (1) . In a typical Western diet, an average of 0.2 mg/kg isoflavones are consumed daily, whereas a typical Asian diet contains >1.5 mg/kg isoflavones per day (2) , which can raise individual human isoflavone serum levels to 500 nM (3) . For infants fed soy-based formulas, isoflavone intake can reach 9.3 mg/kg·bw/day (4) .
Various studies have demonstrated that isoflavones provide a protective barrier against cancers, osteoporosis, menopausal syndromes and cardiovascular diseases (5) (6) (7) (8) (9) . These findings have evoked strong public and academic interest in isoflavones. However, the negative effects of isoflavones, particularly on the male reproductive system, have also been reported (10) . Previous studies demonstrated that isoflavones may produce male reproductive toxicity; their main adverse effects on the male reproductive system include the disturbance of sex hormone release (11, 12) , interference with the onset of puberty (13) , altering penile corpus cavernosum structure, weakening erectile function (14, 15) , suppressing the activity of some steroidogenesis-associated enzymes (16) , and decreasing the weight and epithelial height of accessory sex organs (12) . Furthermore, a high intake of soy-based food and soy isoflavones is associated with reduced sperm concentration, as demonstrated in animal experiments and human epidemiological studies (17, 18) . As aforementioned, infants fed soy-based formulas may be exposed to isoflavones, which may exert potential adverse effects. Although previous in vivo experiments have been conducted to determine the effects of isoflavone exposure on the testes (10) , data regarding exposure to isoflavones during the early neonatal period is limited.
The mechanism underlying the effects of isoflavone exposure on male reproductive function is not fully understood.
Several studies have reported that the effects of isoflavone exposure differ to those of estradiol (19) , which implies that they may have different mechanisms of action. Isoflavones can suppress testosterone production in Leydig cells by direct inhibition of 3β-hydroxysteroid dehydrogenase (3β-HSD) activity, and induce adiponectin secretion, which can further suppress steroidogenic acute regulatory protein (StAR) expression and decrease testosterone (20) . However, existing studies cannot fully explain the observed toxic phenomena associated with isoflavone exposure; for example, the associated decreased testosterone levels and sperm count.
The present study aimed to explore the effects of daidzein, a major type of isoflavone, on testes in the early neonatal period. A testis culture system was used, in which the testicular architecture was conserved and its development remains similar to that in vivo (21, 22) , in order to explore the effects of daidzein exposure on steroidogenesis and Sertoli cell function. A cell culture experiment was also performed. The results of the present study may partially explain the adverse effects of daidzein on testes.
Materials and methods
Reagents. Daidzein (CAS# 486-66-8; purity ≥98%) was purchased from Sigma-Aldrich (Merck Millipore, Darmstadt, Germany). Daidzein stock solution was generated using dimethyl sulfoxide (DMSO; Amresco, LLC, Cleveland, OH, USA) and was diluted in culture medium.
Experimental animals. Male neonatal mice (postnatal day 4) Kunming mice were obtained from the Experimental Animal Center of Sichuan University (SYXK 2009-045; Chengdu, China) and 10-15 mice were used. The animals were maintained at 25˚C, with access to food and water ad libitum and a 12-h light/dark cycle. All animal studies were conducted in accordance with the principles and procedures for the care and use of laboratory animals. The present study was approved by the ethics committee of West China School of Public Health, Sichuan University (Chengdu, China).
Organ culture and treatment. Organ culture was performed as described in our previous studies (23, 24) . The mice were anesthetized and sacrificed by decapitation. Testes obtained from neonatal mice [postnatal day 4 (PND4), 10-15 mice] were isolated and cut into six to eight pieces. The pieces were pooled and transferred into 50 ml bottles containing 6 ml culture medium; six or more pieces were randomly put into each bottle. The bottles were attached to a rotator at 30 rpm and were incubated at 34˚C for 72 h. Organ culture of the testes was performed in Dulbecco's modified Eagle's medium (DMEM)/F-12 (Hali Biotech, Chengdu, China) supplemented with 10% calf serum (Hali Biotech), 15 mmol/l HEPES (pH 7.4), 5 µg/ml transferrin, 10 µg/ml insulin, 2 mmol/l glutamine, 100 U/ml penicillin G and 100 µg/ml streptomycin. The culture medium was collected and changed daily. Mixed gas comprised of 50% O 2 , 45% N 2 and 5% CO 2 was injected into the bottles to maintain a fresh atmosphere, as previously stated (24, 25) . Testes were assigned to five groups: Control group and daidzein-treated groups (0.03, 0.3, 3 and 30 µmol/l). At the end of the 72 h culture, the testes were fixed for 12 h in Bouin's fluid (trinitrophenol:methanal:ethanoic acid =15:5:1) at 4˚C, embedded in paraffin and cut into 5 µm sections. The media were collected and stored at -80˚C for the subsequent testosterone radioimmunoassay. For mRNA analysis, testes were collected and immediately frozen in liquid nitrogen. Furthermore, 30 µg/ml 5'-bromo-2'-deoxyuridine (BrdU) was mixed into the culture system 3 h prior to testis harvesting to determine proliferation of Sertoli cells. The data were obtained from at least three independently repeated culture bottles.
Leydig cell culture and treatment. Leydig cells were obtained from the testes of male preadolescent mice (10-15 mice; age, 18-21 days) following euthanasia by decapitation under anesthesia. Subsequently, Leydig cells were isolated by a combination of collagenase digestion and Percoll density centrifugation. After digestion with 8 ml collagenase II with 1.5% bovine serum albumin (BSA; Sigma-Aldrich; Merck Millipore) at 35˚C for 25 min, and prior to Percoll density centrifugation, seminiferous tubules were removed by passage of testicular fractions through a 200-mesh filter. The dispersed cells were washed with DMEM/F12 and layered over a Percoll gradient (70, 58, 30 and 5%; Pharmacia Biotech; GE Healthcare, Uppsala, Sweden). The gradient was centrifuged for 30 min at 1,500 x g, and cells localized between Percoll gradient 70 and 58% were isolated. This step ensured the removal of heavier red blood cells and lighter germ cells.
To determine the purity of the target cells, enzyme histochemical and immunocytochemical methods were used to detect 3β-HSD. After a 24 h culture period, purified Leydig cells were incubated for 60 min at 34˚C in a phosphate buffer solution containing 10% nitroblue tetrazolinum (Amresco, LLC), 10% nicotanamide adenosine dinucleotide (Amresco, LLC), 6% DHEA (Merck Millipore) and 6% DMSO (26) . Positive cells (containing blue granules) were identified as Leydig cells. In addition, Leydig cell slides were fixed with 4% paraformaldehyde, and were then immunostained according to standard protocol. Briefly, fixed cell slides were treated with 5% Triton X-100 and sealed with 5% BSA. Subsequently, the slides were incubated with 3β-HSD antibodies (1:800; BIOSS, Beijing, China; cat. no. bs-3906R) overnight at 4˚C, then incubated with a secondary antibody working solution from an immunohistochemistry kit (SP-9000; ZSGB-BIO) for a further 15 min at room temperature, followed by incubation with avidin-biotin peroxidase complex for 15 min. DAB was used as the chromogen and slides were observed under a light microscope. Leydig cells were typically 90% pure as assessed by these two staining methods.
Leydig cells were cultured in the same DMEM/F12 medium as the organ culture. Leydig cells (3x10 5 /1 ml medium) were plated into six-well plates and were cultured at 34˚C in a humidified atmosphere containing 95% air and 5% CO 2 . A total of 1 day after plating, fresh medium was added, and treatments were initiated. Doses of daidzein were added to wells in triplicate, and cells were cultured at 34˚C in a humidified atmosphere containing 5% CO 2 for 24 h. Subsequently, the medium was collected and stored at -20˚C until further analysis.
Assessment of cellular viability. Cellular viability was evaluated using the MTT proliferation assay. Briefly, cells were plated in a 96-well plate at a density of 10,000 cells/well. Histopathology and immunohistochemistry. Histopathological evaluation was conducted using hematoxylin and eosin (H&E) staining. Following fixation in Bouin's fixative and dehydration, the testes were embedded in paraffin and cut into 5 µm sections. Sections from the testes were stained with H&E for histopathological evaluation, hematoxylin was applied for 5 min and eosin for 2 min (both at room temperature). Protein expression in tissue was detected by immunohistochemical staining. Serial sections (5 µm) were then mounted on slides, deparaffinized with xylene twice for 15 min and rehydrated in an alcohol gradient. The sections were then immunostained with antibodies according to manufacturer's protocol. For antigen retrieval, sections were microwaved at 450 W in 10 mmol/l citrate buffer solution. For all immunohistological procedures, slides were treated with Triton X-100 for 1 min, and were then incubated in 0.3% H 2 O 2 for 10 min and in 5% normal goat serum albumin (ZSGB-BIO, Beijing, China) in PBS for 1 h, in order to block nonspecific antigen-binding. Subsequently, the slides were incubated with the following primary antibodies: Anti-3β-HSD (1:800), anti-cholesterol side chain cleavage enzyme (P450scc; 1:200; Wuhan Boster Biological Technology Co., Ltd., Wuhan, China; cat. no. BA3699), anti-17α-hydroxylase/20-lyase (P450C17α; 1:200; BIOSS; cat. no. bs-6695R), anti-vimentin (1:400; BIOSS; cat. no. bs-8533R) and anti-BrdU (1:100; Sigma-Aldrich; Merck Millipore; cat. no. B2531) overnight at 4˚C. The primary antibodies were detected by incubation with a secondary antibody working solution from a immunohistochemistry kit (SP-9000; ZSGB-BIO) for a further 15 min at room temperature, followed by incubation with avidin-biotin peroxidase complex (Vector Laboratories, Inc., Burlingame, USA) for 15 min. 3',3'-Diaminobenzidine (ZSGB-BIO) was used as the chromogen and hematoxylin as the nuclear counterstain. Negative control refers to samples in which the primary antibody was omitted. Staining was observed under a light microscope.
RNA extraction, reverse transcription and quantitative polymerase chain reaction (qPCR).
Testes were collected and homogenized, followed by total RNA extraction from the testes and cells using the MicroElute Total RNA kit (Omega Bio-tek, Norcross, GA, USA), and 0.8 µg total RNA was reverse transcribed using Oligo (dT) 18 primers and RevertAid M-MuLV reverse transcriptase (Thermo Fisher Scientific, Inc., Waltham, MA, USA) in a 20 µl reaction mixture, according to the manufacturer's protocol. To determine the expression levels of mRNAs that code for proteins implicated in the steroidogenic pathway (StAR, P450scc, P450C17α and 3β-HSD), qPCR amplification was performed using a Bio-Rad CFX96 Detector system and SsoFast EvaGreen Supermix (Bio-Rad Laboratories, Inc., Hercules, CA, USA). A reaction volume of 10 µl was used containing 2 µl cDNA, 5 µl supermix, 0.2 µl each primer and 2.6 µl RNase/DNase-free water. The thermocycling conditions were as follows: Initial denaturation at 95˚C for 30 sec; followed by 35 cycles of 95˚C for 5 sec and Tm for 5 sec. Tm was 60˚C for StAR and p450c17α, 55˚C for P450scc and 3β-HSD, 56.3˚C for inhibin B, 57.4 for vimentin and 57.4 for β-actin. In testes, the expression levels of inhibin B and vimentin were also detected. The primers used were as follows: StAR, forward (f) 5'-cgg gtg gat ggg tca agt tc-3' , reverse (r) 5'-cca agc gaa aca cct tgcc-3'; p450scc, f 5'-aca tgg cca aga tgg tac agt tg-3' , r 5'-acg aag cac cag gtc att cac-3'; 3β-HSD, f 5'-tgg aca aag tat tcc gac caga-3' , r 5'-ggc aca ctt gct tga aca cag-3'; p450c17α, f 5'-tga cca gta tgt agg ctt cag tcg-3', r 5'-tcc ttc ggg atg gca aac tctc-3'; vimentin f 5'-cgt cca cac gca cct acag-3', r 5'-ggg gga tga gga ata gag gct-3'; and inhibin B, f 5'-ctt cgt ctc taa tga agg caa cc-3', and r 5'-ctc cac cac att cca cct gtc-3'. Gene expression was normalized to the housekeeping gene β-actin: F 5'-ggc tgt att ccc ctc cat cg-3' and R 5'-cca gtt ggt aac aat gcc atgt-3', and expression levels are presented relative to vehicle control (DMSO) at the same time point. All samples were run together in triplicate. Quantification cycle (Cq) values obtained for triplicates were averaged and normalized to β-actin for each RNA sample. Analyses were performed using the 2 -ΔΔCq method (27) .
Western blot analysis. Leydig cells were washed with PBS and lysed in cell lysis/extraction reagent (Nanjing KeyGen Biotech, Co., Ltd., Nanjing, China), including phenylmethanesulfonyl fluoride. Protein concentration was quantified using the Bradford method. Proteins (40 µg) were separated by 10% SDS-PAGE, and were then electrophoretically transferred onto polyvinylidene fluoride (PVDF) membranes. (Fig. 1A) . However, testosterone secretion by PND4 testes during 3 days of culture was reduced following incubation with 30 µmol/l daidzein (Fig. 1B) .
Daidzein alleviates StAR and steroidogenic enzyme expression in testes.
To determine the effects of daidzein on steroidogenic-related protein and enzyme expression in neonatal testes, qPCR and immunohistochemical analysis were performed. After 72 h culture with or without daidzein, the mRNA expression levels of StAR, P450scc and 3β-HSD, which are involved in the steroidogenic process, were downregulated following treatment with 30 µmol/l daidzein compared with the control (P<0.05; Fig. 2A ). No obvious changes in the mRNA expression levels of P450C17α were detected .
Corresponding with the findings of qPCR, the protein expression levels of P450scc and 3β-HSD in the testes were reduced following treatment with 30 µmol/l daidzein (Fig. 2B) . No marked change in P450C17α staining intensity was detected.
Exposure to daidzein reduces testosterone production, and alters the expression of StAR and steroidogenic enzymes in Leydig cells.
To further verify the effects of daidzein on testosterone production in testes, the present study investigated testosterone secretion, and StAR, P450scc, 3β-HSD and P450C17α expression in Leydig cells in vitro. Cell viability was analyzed by MTT assay, and no changes were observed (Fig. 3A) . Consistent with organ culture, incubation with 30 µmol/l daidzein induced a marked suppression of testosterone production by Leydig cells compared with in the control cells (P<0.05; Fig. 3B ). The qPCR results indicated that the mRNA expression levels of StAR, P450scc, 3β-HSD and P450C17α were lower following treatment with 30 µmol/l daidzein compared with the control (P<0.05; Fig. 3C ).
The present study also examined the protein expression levels of StAR, P450scc, 3β-HSD and P450C17α in Leydig cells. StAR, P450scc, 3β-HSD and P450C17α protein expression levels were decreased in Leydig cells exposed to daidzein (Fig. 3D) . Collectively, these effects on mRNA and protein expression indicate that a general downregulation of the steroid synthesis pathway leads to the observed low testosterone levels. 
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Daidzein inhibits Sertoli cell proliferation in cultured neonatal mouse testes.
To investigate the effects of daidzein exposure on Sertoli cells in mouse testes, cell proliferation was analyzed with BrdU staining. A total of 3 hours after BrdU was mixed into the culture system, some labeled cells were observed in the seminiferous tubules and in the interstitium of the testes. The number of labeled Sertoli cells was reduced in the testes following treatment with 30 µmol/l daidzein ( Fig. 4A and B) .
Daidzein inhibits vimentin expression in cultured neonatal mouse testes.
To further determine the effects of daidzein on Sertoli cells in neonatal testes, the expression levels of vimentin were analyzed. Vimentin mRNA expression levels were markedly lower following treatment with 30 µmol/l daidzein compared with the control (P<0.05; Fig. 5A ). In addition, immunostaining of Sertoli cells in daidzein-treated (30 µmol/l) testes was weaker compared with the control (Fig. 5B) .
Exposure to daidzein has no effect on inhibin B expression in neonatal mouse testes. The effects of daidzein on the expression levels of inhibin B, which is a regulator involved in steroidogenesis, were also analyzed. As shown in Fig. 6A , the mRNA expression levels of inhibin B exhibited no alteration following treatment with daidzein. Consistent with this result, the levels of inhibin B secreted by testes exhibited no difference between daidzein-treated testes and controls (Fig. 6B) .
Discussion
Daidzein is an active isoflavone, which is widely consumed in the East. The present study focused on the effects of daidzein on testosterone biosynthesis and Sertoli cell function in neonatal mouse testes. The results demonstrated that daidzein was able to decrease testosterone synthesis in vitro, and the decrease was preceded by alterations in related protein expression, e.g. StAR, P450scc and 3β-HSD. In addition, the present data illustrated that high doses of daidzein may exert adverse effects on Sertoli cells in neonatal mouse testes. The present study investigated the effects of daidzein on testes during the early neonatal period in vitro using a testis culture system, since the dose of delivered isoflavone to pups via milk is difficult to control. The dose has been shown to be thousands of times lower compared with the dose delivered by maternal diet (28) . Furthermore, the period of infancy is much longer in humans than it is in mice. Therefore, the testis culture method was chosen to determine the direct effects of daidzein on early neonatal mouse testes (PDN4). 
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Testis culture was initially used in reproductive physiology studies, including those focused on spermatogenesis, meiosis and development (29) (30) (31) (32) . In addition, the organ culture method has been used to develop novel applications in toxicological studies, allowing in vitro functional screening tools to select exogenous compounds for further in vivo evaluation (33, 34) . Cell lines or primary cultures are limited, since most only poorly mimic the physiological situation; however, organ culture can preserve intercellular relationships in tissue (35) .
The present study demonstrated that short exposure to high concentrations of daidzein may lead to reduced testosterone levels, without histopathological changes, in neonatal mouse testes, which consisted with the results of a previous study (10) . Pan et al reported that genistein exposure at 20 and 100 mg/kg/day was able to adversely affect testosterone production (15) . Furthermore, Lehraiki et al reported that genistein impairs early testosterone production in fetal mouse testes in vitro (22) . Genistein at a dose of 213 mg/kg.bw/day from gestational day 7 to PND13 also reduced plasma testosterone levels in rat offspring (36) . Similarly, a clear downtrend tendency in plasma testosterone levels was detected in primary Leydig cells treated with 30 µmol/l daidzein, which is similar to the results of Opalka et al (37, 38) . Nevertheless, no adverse effect on proliferation was detected in Leydig cells treated with 30 µmol/l daidzein. The present findings identified a potential harmful effect of daidzein exposure on testis steroidogenesis function during the early neonatal period.
Although the association between isoflavone exposure and reduced testosterone production has been defined, the toxicant mechanism remains unclear. Suppression of StAR and steroidogenic enzymes (P450scc, 3β-HSD and P450C17α) has been suggested as toxicant mechanisms underlying reduced testosterone levels (39, 40) . Testosterone production can be inhibited by exogenous compounds via the suppression of StAR, P450scc and 3β-HSD (41, 42) . The present results detected reduced expression levels of StAR, P450scc and 3β-HSD in the neonatal testes when treated with a high concentration of daidzein. Consistent with this result, it has previously been reported that genistein, another type of isoflavone, suppresses StAR, P450scc, 3β-HSD and P450C17 expression, and decreases testosterone production in fetal testes (22) . These findings may explain why testosterone levels in the testis or plasma are decreased following treatment with isoflavones.
Concurrently, the expression levels of StAR and steroidogenic enzymes were assessed in daidzein-treated Leydig cells, in order to further verify the mechanistic activities of daidzein on factors associated with steroid synthesis. The results demonstrated an apparent decline in mRNA and protein expression levels of StAR, P450scc, 3β-HSD and P450C17, which are consistent with the organ culture results. With regards to P450C17α, the discrepancy in expression levels between the testes and Leydig cells may be due to different levels of sensitivity to isoflavones. Leydig cells are known to be more sensitive to exogenous agents compared with organ culture (43) .
Prior to the onset of puberty, immature Sertoli cells proliferate in parallel to spermatogonia until the seminiferous epithelium reaches its final size (44) . Our previous study indicated that isoflavone exposure can downregulate follicle-stimulating hormone receptor, transferrin and vimentin mRNA expression in Sertoli cells in vitro (45) . The present results demonstrated that 30 µmol/l daidzein was able to interfere with Sertoli cell proliferative activity in neonatal mouse testes in vitro, thus implying a potential adverse effect on spermatogenesis.
The present study also detected reduced expression levels of vimentin, which is an essential Sertoli cell cytoskeletal protein, following treatment with daidzein. Previous studies have demonstrated that endocrine disruptors can alter the expression of vimentin in vitro and in vivo (46, 47) . In the present study, the mRNA and protein expression levels of vimentin were reduced in daidzein-exposed testes; these results are similar to our previous study (45) . These findings demonstrated that vimentin may be sensitive to daidzein treatment. Reduced vimentin expression may help to explain the increased germ cell apoptosis, which was observed in China mini-pig boars following exposure to 250 ppm soy isoflavone for 60 days (12) . The association between altered vimentin expression and reproductive toxicity due to isoflavone exposure remains unclear. Therefore, further research is required to clarify these associations and the mechanisms by which isoflavone exerts effects on vimentin expression.
Inhibin B, which is secreted by Sertoli cells, reflects spermatogenesis function in the testes, and, is an essential biomarker of reproductive toxicity. Concentration of inhibin B is correlated with testicular histology structure (48) , sperm concentration and sperm count (49) . Decreased inhibin B levels may predict impaired secretory function of Sertoli cells and damaged testicular spermatogenesis (50) . However, in the present study, no clear effects on inhibin B mRNA expression were detected in the neonatal testes. Similarly, concentrations of inhibin B in the supernatant were not altered in testes exposed to daidzein in vitro. Therefore, inhibin B may not be affected following daidzein exposure.
In conclusion, early neonatal exposure to daidzein elicits adverse effects on testosterone biosynthesis and Sertoli cell function. Daidzein exposure may inhibit the expression of StAR and steroidogenic enzymes (P450scc and 3β-HSD). In addition, the results of the present study revealed that exposure to daidzein reduces the expression of vimentin in Sertoli cells, predicting a potential adverse effect on sperm development. Therefore, these results indicate that isoflavones exert potential harmful effects on immature testes; however, the detailed mechanism of action of this phytochemical remains to be elucidated. Further studies investigating the effects of isoflavones on Sertoli cells are required to adequately understand the role of isoflavones in sperm development.
